BCL2L11 and cancer: Our study indicated that CKI represents a promising radioprotective agent with a potential differential beneficial effect on both cancer cells (inducing apoptosis) and HSF cells (providing radio-protection via inhibiting IR-induced apoptosis) as clearly demonstrated through this study, via regulation of mitochondria pathway by regulating Bim.